FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
116 letters match. Newest first.
-
DrugsConroe Welding Supply, Inc.
FDA warns Conroe Welding Supply over medical oxygen manufacturing failures, including untested batches and a container with 99% (b)(4).
High risk -
DrugsPritam International Private Limited
Pritam International, an Indian OTC drug maker, was cited for CGMP violations, falsified lab data, unsafe color additive, and DEG/EG testing gaps.
High risk -
DrugsLovelace Biomedical Research Institute
Lovelace Biomedical's quality unit failed to ensure final drug study reports matched raw data, FDA says.
Medium -
FoodOcean Pride Seafood, Inc.
FDA warned Ocean Pride Seafood that its ready-to-eat seafood was adulterated (unsafe under law) due to missing seafood safety (HACCP) controls and insanitary conditions.
High risk -
DrugsPine Pharmaceuticals, LLC
FDA cited outsourcing facility Pine Pharmaceuticals in Tonawanda, NY, for insanitary sterile compounding conditions and CGMP failures after a November 2025 inspection.
High risk -
AnimalDeJong Family Dairy, LLC
FDA warned DeJong Family Dairy that it treated cows with an animal drug in ways the label and a veterinarian did not allow.
Medium -
DrugsShimoga Chemicals
FDA warns Shimoga Chemicals of manufacturing quality and data integrity failures in clomiphene citrate active ingredient.
High risk -
Devices3B Medical, Inc. dba Reach Health, Inc.
FDA warns Reach Health over unapproved APAP use change and complaint/CAPA failures.
High risk -
FoodAversa's Italian Bakery
FDA warns Aversa's Italian Bakery over missing food safety plan and undeclared sesame/milk allergens in ready-to-eat rolls.
High risk -
DrugsHealthPartners Neuroscience Center Research and Innovation
FDA warned HealthPartners Neuroscience Center that its animal studies of an investigational drug violated good laboratory practice rules.
Medium -
FoodCity Market, Inc.
FDA cited City Market, Inc. for insanitary conditions and seafood safety plan (HACCP) failures involving ready-to-eat pasteurized canned crab meat.
High risk -
DrugsLexia LLC
FDA cited Lexia for manufacturing violations in an OTC topical pain relief drug, including missing release and component testing.
High risk -
DrugsPro Numb Tattoo Numbing Spray, LLC
FDA cited Pro Numb Tattoo Numbing Spray for selling unapproved, misbranded numbing drugs and manufacturing quality failures after a November 2025 inspection.
High risk -
FoodSchlechter Farms Inc.
FDA found bird feces throughout Schlechter Farms' Oregon onion packing shed, adulterating onions and repeating 2023 violations.
High risk -
DrugsMicrobiological Testing & Consulting, LLC
FDA warned contract testing lab Microbiological Testing & Consulting over CGMP violations in drug product microbiological testing.
High risk -
DevicesExactech, Inc. dba Advita Ortho
FDA warned Exactech/Advita Ortho over quality-system failures in Equinoxe shoulder implants found during a July 2025 Sarasota inspection.
High risk -
DrugsBertrand P. Cole, D.O.
FDA warns Dr. Bertrand P. Cole that he gave four trial subjects too much drug by not following the study plan.
High risk -
DrugsMark S. Dacey, M.D.
FDA warns Dr. Mark S. Dacey that a trial subject underwent an optional eye-fluid sampling procedure after twice declining consent.
High risk -
FoodMaui Seafood LLC
Maui Seafood LLC's Las Vegas RTE tuna and salmon plant had Listeria monocytogenes (a harmful bacterium) and seafood safety plan sanitation violations.
High risk -
DevicesPalamur Biosciences Private Limited
FDA warns Palamur Biosciences over GLP violations in medical device safety testing and inadequate corrective actions.
High risk -
BiologicsMicrovascular Tissue, Inc.
FDA says Microvascular Tissue's mVASC wound product is an unapproved drug and unlicensed biologic, made without validated processes.
High risk -
FoodBedner Growers, Inc.
FDA: Bedner Growers' cucumbers tied to Salmonella outbreaks; packing line and product tested positive.
High risk -
DrugsDeVere Manufacturing Inc.
FDA warned DeVere Manufacturing in Janesville, Wisconsin, that its OTC hand sanitizers are adulterated after a June 2025 inspection found CGMP failures.
High risk -
FoodDelicias Del Country USA Inc
Delicias Del Country USA, a Laredo, Texas food importer, had no Foreign Supplier Verification Program for imported cakes and pastries.
Medium -
DevicesSeniorLife Technologies, Inc.
FDA warns SeniorLife Technologies that its SeniorLife.AI app is unapproved and misbranded, with quality-system and reporting failures.
High risk -
DevicesJiangsu Kerbio Medical Technology Group Co.
FDA cites Jiangsu Kerbio Medical Technology Group for serious GLP violations in medical device safety testing.
High risk -
DevicesCCIC Huatongwei International Inspection Co., Ltd.
FDA warns CCIC Huatongwei after inspection found copied data and missing records in medical device safety tests.
High risk -
DevicesLes Encres LLC
FDA warns Les Encres that its PDO surgical suture threads were promoted for unapproved cosmetic uses and had quality system violations.
High risk -
DevicesSpectra Therapy, LLC
FDA warns Spectra Therapy over LASERwrap infrared lamp device quality-system violations and unapproved disease-treatment claims.
High risk -
DrugsXtreme Tools International, Inc.
FDA warned Xtreme Tools International after an inspection found manufacturing-rule failures for OTC topical drugs, including missing ingredient and batch testing.
High risk -
DrugsPeter Michael, M.D.
FDA warns clinical investigator Peter Michael, M.D. that pediatric trial subjects received twice the protocol's maximum drug dose.
High risk -
DrugsHealwell Homeo Private Limited
FDA warns Healwell Homeo over pest-infested drug storage and manufacturing violations.
High risk -
DrugsStaska Pharmaceuticals, Inc.
FDA warns Staska Pharmaceuticals, a Nebraska outsourcing facility, that sterile compounded drugs had contamination risks and labeling problems.
High risk -
FoodUnited King Foods Private Limited
FDA warned United King Foods over serious low-acid canned food processing violations for Gulab Jamun exported to the U.S.
High risk -
FoodWailea Agricultural Group, Inc.
Wailea Agricultural Group's hearts of palm were adulterated after FDA found E. coli in water used for handwashing and cleaning.
High risk -
DevicesKabe Labortechnik GmbH
Kabe Labortechnik lacked validated processes and design controls for SAFE-T-FILL blood collection tubes, FDA found.
High risk -
DrugsBioAsia Worldwide Sdn Bhd
FDA warned BioAsia Worldwide over current good manufacturing practice violations for OTC drugs.
High risk -
DevicesEpiCare Acquisitions, LLC
FDA warns EpiCare Acquisitions over unvalidated EpiCare-Zenith lasers and flawed complaint, corrective-action, record, training, and reporting procedures.
High risk -
DrugsYangzhou Sion Commodity Co., Ltd.
FDA warned Yangzhou Sion Commodity over drug manufacturing failures, including untested high-risk ingredients and unreliable lab records.
High risk -
DevicesExer Labs, Inc.
Exer Labs marketed its Exer Scan device for AI diagnosis and treatment without FDA approval or clearance and lacked quality procedures.
High risk -
DrugsRite-Kem Incorporated
FDA warned Rite-Kem over inadequate current good manufacturing practice testing of over-the-counter drugs, including hand sanitizers and antimicrobial products.
High risk -
DrugsChem-Tech, Ltd.
Chem-Tech, Ltd. lacked adequate investigations and clean equipment for its OTC drug.
High risk -
DrugsABR Laboratory LLC
FDA warned ABR Laboratory, a contract drug testing lab, that unverified microbial test methods and missed investigations made tested drugs adulterated.
High risk -
FoodMiyajima Shoyu Co., Ltd.
Miyajima Shoyu lacked FDA-filed scheduled processes for acidified Wasabi Dressing, making it adulterated.
High risk -
DrugsDr. Brite, LLC
FDA cited Dr. Brite for manufacturing quality failures and selling unapproved, misbranded oral care and hand sanitizer drugs.
High risk -
FoodAgustson A/S
Agustson A/S exported acidified seaweed caviar to the US without following filed scheduled processes and process controls.
High risk -
FoodAdvance Nature Sdn Bhd
FDA warns Malaysia's Advance Nature over inadequate heat-process controls for exported low-acid bamnut milk.
High risk -
DrugsRichard W. Foltin, Ph.D.
FDA warned sponsor Dr. Richard W. Foltin for starting drug trials in people without an IND.
High risk -
BiologicsNamita A. Goyal, M.D.
FDA warned clinical investigator Dr. Namita Goyal over a biologic trial that enrolled ineligible subjects and kept poor records.
High risk -
BiologicsHemarus LLC
Hemarus LLC failed blood-product manufacturing rules, including unapproved donor reinstatement and records signed when physician absent.
High risk